[Novel agents for the therapy of castration-resistant prostate cancer: overview of pivotal studies and new strategies to come]. [electronic resource]
Producer: 20130830Description: 1-7 p. digitalISSN:- 1166-7087
- Androstenes
- Androstenols -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzamides
- Clinical Trials as Topic
- Clinical Trials, Phase III as Topic
- Denosumab
- Disease-Free Survival
- France -- epidemiology
- Humans
- Male
- Nitriles
- Orchiectomy
- Phenylthiohydantoin -- administration & dosage
- Prostatic Neoplasms -- drug therapy
- Radioisotopes -- administration & dosage
- Radium -- administration & dosage
- Randomized Controlled Trials as Topic
- Survival Rate
- Taxoids -- administration & dosage
- Tissue Extracts -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.